These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28292020)

  • 1. Long non-coding RNA HNF1A-AS1 promotes hepatocellular carcinoma cell proliferation by repressing NKD1 and P21 expression.
    Wang C; Mou L; Chai HX; Wang F; Yin YZ; Zhang XY
    Biomed Pharmacother; 2017 May; 89():926-932. PubMed ID: 28292020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HNF1α-regulated lncRNA HNF1A-AS1 reverses the malignancy of hepatocellular carcinoma by enhancing the phosphatase activity of SHP-1.
    Ding CH; Yin C; Chen SJ; Wen LZ; Ding K; Lei SJ; Liu JP; Wang J; Chen KX; Jiang HL; Zhang X; Luo C; Xie WF
    Mol Cancer; 2018 Feb; 17(1):63. PubMed ID: 29466992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA DDX11-AS1 epigenetically represses LATS2 by interacting with EZH2 and DNMT1 in hepatocellular carcinoma.
    Li Y; Zhuang W; Huang M; Li X
    Biochem Biophys Res Commun; 2019 Jul; 514(4):1051-1057. PubMed ID: 31097223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p.
    Liu Z; Wei X; Zhang A; Li C; Bai J; Dong J
    Biochem Biophys Res Commun; 2016 May; 473(4):1268-1275. PubMed ID: 27084450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21.
    Wei C; Wang H; Xu F; Liu Z; Jiang R
    Biomed Pharmacother; 2018 Aug; 104():137-144. PubMed ID: 29772433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D; Lu X; Su J; He X; De W; Yang J; Li W; Han L; Zhang E
    Mol Cancer; 2018 May; 17(1):92. PubMed ID: 29793547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA GATA3-AS1 Promotes Cell Proliferation and Metastasis in Hepatocellular Carcinoma by Suppression of PTEN, CDKN1A, and TP53.
    Luo X; Zhou N; Wang L; Zeng Q; Tang H
    Can J Gastroenterol Hepatol; 2019; 2019():1389653. PubMed ID: 31871924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGR1-Mediated Transcription of lncRNA-HNF1A-AS1 Promotes Cell-Cycle Progression in Gastric Cancer.
    Liu HT; Liu S; Liu L; Ma RR; Gao P
    Cancer Res; 2018 Oct; 78(20):5877-5890. PubMed ID: 30185552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. m
    Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA HNF1A-AS1 upregulates OTX1 to enhance angiogenesis in colon cancer via the binding of transcription factor PBX3.
    Wu J; Meng X; Jia Y; Chai J; Wang J; Xue X; Dang T
    Exp Cell Res; 2020 Aug; 393(2):112025. PubMed ID: 32325080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L; Chen Y; Li Q; Duan P
    J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA FOXD2-AS1 plays an oncogenic role in hepatocellular carcinoma through epigenetically silencing CDKN1B(p27) via EZH2.
    Xu K; Zhang Z; Qian J; Wang S; Yin S; Xie H; Zhou L; Zheng S
    Exp Cell Res; 2019 Jul; 380(2):198-204. PubMed ID: 31004581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DCST1-AS1 functions as a competing endogenous RNA to regulate FAIM2 expression by sponging miR-1254 in hepatocellular carcinoma.
    Chen J; Wu D; Zhang Y; Yang Y; Duan Y; An Y
    Clin Sci (Lond); 2019 Jan; 133(2):367-379. PubMed ID: 30617187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.